Y-2 reduces oxidative stress and inflammation and improves neurological function of collagenase-induced intracerebral hemorrhage rats
In conclusion, Y-2 sublingual tablets might be a promising therapeutic agent for the treatment of ICH.PMID:34536364 | DOI:10.1016/j.ejphar.2021.174507
Source: European Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Yao Hua Limei Zhou Weidong Yang Wenji An Xiaolin Kou Jian Ren Hailang Su Rong Chen Zhengping Zhang Jianjun Zou Zhihong Zhao Source Type: research
More News: Brain | Calcium | China Health | Clinical Trials | Drugs & Pharmacology | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Stroke | Study